Correlation Between Sellas Life and Regeneron Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Sellas Life and Regeneron Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sellas Life and Regeneron Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sellas Life Sciences and Regeneron Pharmaceuticals, you can compare the effects of market volatilities on Sellas Life and Regeneron Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sellas Life with a short position of Regeneron Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sellas Life and Regeneron Pharmaceuticals.

Diversification Opportunities for Sellas Life and Regeneron Pharmaceuticals

0.31

Correlation Coefficient

Sellas Life  Regeneron Pharmaceuticals

Weak diversification

The 3 months correlation between Sellas and Regeneron is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Sellas Life Sciences and Regeneron Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regeneron Pharmaceuticals and Sellas Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sellas Life Sciences are associated (or correlated) with Regeneron Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regeneron Pharmaceuticals has no effect on the direction of Sellas Life i.e., Sellas Life and Regeneron Pharmaceuticals go up and down completely randomly.

Pair Corralation between Sellas Life and Regeneron Pharmaceuticals

Considering the 90-day investment horizon Sellas Life Sciences is expected to generate 2.5 times more return on investment than Regeneron Pharmaceuticals. However, Sellas Life is 2.5 times more volatile than Regeneron Pharmaceuticals. It trades about -0.03 of its potential returns per unit of risk. Regeneron Pharmaceuticals is currently generating about -0.13 per unit of risk. If you would invest  142.00  in Sellas Life Sciences on September 1, 2024 and sell it today you would lose (29.00) from holding Sellas Life Sciences or give up 20.42% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Sellas Life Sciences  vs.  Regeneron Pharmaceuticals

Sellas Life Sciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Sellas Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's essential indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Regeneron Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Regeneron Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Sellas Life and Regeneron Pharmaceuticals

The main advantage of trading using opposite Sellas Life and Regeneron Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sellas Life position performs unexpectedly, Regeneron Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regeneron Pharmaceuticals will offset losses from the drop in Regeneron Pharmaceuticals' long position.

The idea behind Sellas Life Sciences and Regeneron Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.